Success is hard to come by in drug development. “On average, 50% of phase III trials with novel therapeutics fail,” says Subha Madhavan, vice president and head of AI/ML at Pfizer. “A primary reason ...

Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume. Norman Swan: Let's go to the second issue and a really big row that's brewing amongst medical ...

Dr Margaret McCartney and Prof Carl Heneghan explain Clinical vs Statistical Significance Picture credit: Ladies Day at Punchestown racecourse in Ireland. Alan Crowhurst/Getty Images ...

Safety evaluation studies are essential for regulatory approval before a new pharmaceutical can enter clinical phases. Conducted in GLP (Good Laboratory Practice)-certified facilities, these studies ...